Blood Disorder News and Research

RSS

Sickle cell corrected with gene copy

Scientists in the U.S. say they have found a way to use embryonic stem cells to correct the mutation that causes sickle cell disease in mice.

16 Jan 2006

Adult sickle cell drug hydroxyurea proves effective in young children

A drug used for the treatment of sickle cell anemia in adults has now been shown to cause significant improvements in very young children with the disorder.

20 Sep 2005

Researchers have doubled the potency of a protein that drives blood to clot

...according to research to be published in the July 26 edition of Biochemistry. The study results may have profound implications for the treatment of hemophilia, the inherited blood disorder that causes easy or excessive bleeding in 30,000 Americans.

20 Jul 2005

Experimental drug for diabetes looks promising

Encouraging results in a small study, with a new experimental treatment, promises help for certain diabetics to retain some ability to make their own insulin.

29 Jun 2005

British court gives the go ahead for IVF babies to be created to save sick siblings

Britain's highest appeal court has rejected a challenge from an anti-abortion group and has backed a 2003 Court of Appeal ruling that some couples undergoing the fertility treatment could have their embryos screened to find tissue matches for seriously ill children. The procedure will help save desperately ill children but some fear it could lead to the creation of babies for spare parts

1 May 2005

Genetic screening for iron blood disorder feasible in the workplace

Screening for a condition called haemochromatosis, where iron to builds up in the body, could help prevent organ damage and disease, suggests a study published online today by The Lancet.

26 Apr 2005

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

5 Dec 2004

Experimental drug PKC412 may be the key to treating myeloproliferative disease

Scientists at Dana-Farber Cancer Institute and Brigham and Women's Hospital have prolonged the lives of mice with a rare blood disorder by using an experimental drug that blocks signals promoting runaway growth of blood cells.

21 Sep 2004